Diabetes mellitus and other associated comorbidities as a poor prognostic factor in patients with COVID-19
Keywords:
COVID-19, SAR-CoV-2, diabetes mellitus, high blood pressure, obesity, cardiovascular diseasesAbstract
The current pandemic, generated by the new coronavirus called severe acute respiratory syndrome, coronavirus 2, causes the disease known as COVID-19, which can present severe forms with high mortality; patients with diabetes mellitus and associated comorbidities have a worse prognosis. A review of the existing literature was carried out in databases such as MEDLINE, LILACS, SciELO, LATINDEX, MEDIGRAPHY, MEDSCAPE, Science Direct Elsevier, PubMed and World Health Organization/Pan American Health Organization, bulletins as well as the INFOMED Portal, with the aim of evaluating some aspects related to the increase in mortality in this particular group. A total of 83 articles were reviewed, 24 were selected. Diabetes mellitus and related comorbidities constitute a poor prognosis in the evolution of patients with COVID-19.
Downloads
References
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol [Internet]. 2020[citado 6 jul 2020];17(5):259-60 (2020).Disponible: https://doi.org/10.1038/s41569-020-0360-5
Emami A, Javanmardi F. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Arch Acad Emerg Med[ Internet]. 2020 [citado 6 jul 2020]; 8(1): [aprox. 12 p.]. Disponible: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096724/
Serra Valdés M. Las enfermedades crónicas no transmisibles y la pandemia por COVID-19. Revista Finlay [Internet]. 2020 [citado 6 Jul 2020]; 10(2): [aprox. 10 p.]. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/846
Fadini GP, Morieri ML, Longato E, Avogaro A .Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrino lInvest [Internet]. 2020 [citado 6 jul 2020]; 43:867–9. Disponible: https://doi.org/10.1007/s40618-020-01236-2
Longo M, Caruso P, Maiorino MI. Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies. Cardiovasc Diabetol [Internet]. 2020[citado 6 Jul 2020];19: [aprox. 11 p.]. https://doi.org/10.1186/s12933-020-01090-9
Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID ‐19. Diabetes MetabSyndr. [Internet]. 2020 [citado: 6 jul 2020]; 14(4): [aprox. 10 p.]. Disponible: https://onlinelibrary.wiley.com/doi/full/10.1002/dmrr.3319
Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev[Internet]. 2020 [citado: 6 jul 2020];36(7):e332113321. Disponible https://link.springer.com/article/10.1007/s40618-020-01236-2
Huang I, Lim MA. PranataR. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression. Diabetes &Metabolic Syndrome: ClinicalResearch&Reviews [Internet]. 2020 [citado 6 Jul 2020];14(4):395-403. Disponible: https://www.sciencedirect.com/science/article/pii/S1871402120300837
Tay MZ, Poh CM, Rénia L. The trinity of COVID-19: immunity, inflammation and intervention. NatRevImmunol[Internet]. 2020[citado 31 Jul 2020];20(6):363-74. Disponible en https://doi.org/10.1038/s41577-020-0311-8
Serra Valdés MA. COVID-19. De la patogenia a la elevada mortalidad en el adulto mayor y con comorbilidades. Revista Habanera de Ciencias Médicas [Internet]. 2020 [citado 31 Jul 2020];19(3):[aprox. 6 p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3379
Samada Suárez M, Hernández Perera JC , Piñeiro Pérez D. ¿El SARS-C0V-2 puede ser diabetógeno? Boletín Científico del Cimeq [Internet]. 2020 Jul [citado 6 jul 2020]; 1(16): [aprox. 8 p.]. Disponible https://instituciones.sld.cu/bolcimeq/2020/07/06/el-sars-c0v-2-puede-ser-diabetogeno/#more-425
Aguilera Batista O, Bruzón Laguna E de la C. Recomendaciones prácticas para el manejo de los pacientes diabéticos con la COVID-19. Boletín Científico del Cimeq [Internet]. 2020 [citado 4 Ago 2020];1(12):4-5. Disponible en: https://instituciones.sld.cu/bolcimeq/2020/06/08/recomendaciones-practicas-para-el-manejo-de-los-pacientes-diabeticos-con-la-covid-19/
Mejía F, Medina C, Cornejo E, Morello E, Vásquez S, Alave J et al. Clinical features and prognostic factors related to mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru [Internet].2020 Jun[citado 4 Ago 2020]. Disponible; https://preprints.scielo.org/index.php/scielo/preprint/view/858/
Preciado-Ortiz ME , Sánchez-Reyes K , Álvarez-Zavala M , González-Hernández LA , Ramos-Solano M , Andrade-Villanueva J. Obesidad e infecciones REVISTA MÉDICA MD [Internet]. 2018 [citado 4 Ago 2020];9(4):[aprox. 8 p.]. Disponible: https://www.medigraphic.com/pdfs/revmed/md-2018/md184n.pdf
Stefan N, Birkenfeld AL, Schulze MB. Obesity and impaired metabolic health in patients with COVID-19. NatRevEndocrinol [Internet]. 2020 [citado 4 Ago 2020]; 16:341-2. Disponible: https://doi.org/10.1038/s41574-020-0364-6
Luis Miguel Miranda-Garduño* y Alfredo Reza-Albarrán. Obesidad, inflamación y diabetes. GacMédMéx[Internet].2008 [citado 4 Ago 2020];144(1): [aprox. 12 p.]. Disponible :https://www.medigraphic.com/pdfs/gaceta/gm-2008/gm081h.pdf
Dietz W, Santos‐Burgoa C. Obesity and its Implications for COVID‐19 Mortality. Obesity [Internet]. 2020 [citado 6 Jul 2020); 28(6): [aprox. 13 p.]. Disponible: https://onlinelibrary.wiley.com/doi/full/10.1002/oby.22818
Bell Castillo Josefa, George CarriónWilberto, GarcíaCéspedesMaría Eugenia, Delgado Bell Evelyn, George Bell María de Jesús. Identification of metabolic syndrome in patients with diabetes mellitus and hypertension.MEDISAN [Internet]. 2017 Oct [citado 4 Ago 2020];21(10):3038-45. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192017001000007&lng=es
Chen Q, Zheng Z, Zhang C. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection[Internet]. 2020[citado 6 Ago 2020];48(4):543-51. Disponible: https://doi.org/10.1007/s15010-020-01432-5
Valdés Ramos E, Bencosme Rodríguez N. Frecuencia de la hipertensión arterial y su relación con algunas variables clínicas en pacientes con diabetes mellitus tipo 2. Rev Cubana Endocrinol [Internet]. 2009 Dic [citado 4 Ago 2020]; 20(): 77-88. Disponible en: http://scielo.sld.cu/scielo.php?
Giralt-Herrera A, Rojas-Velázquez JM, Leiva-Enríquez J. Relación entre COVID-19 e Hipertensión Arterial. Revhabanciencméd [Internet]. 2020 [citado 4 Ago 2020]; 19(2):e_3246. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3246
Hipertensión Arterial .La Hipertensión Arterial podría elevar el riesgo de muerte por COVID-19 [citado 4 Ago 2020]. Disponible: https://www.drugs.com/news/blood-pressure-might-raise-covid-19-death-risk-
Ikizler TA, Kliger AS. Minimizing the risk of COVID-19 among patients on dialysis. NatRevNephrol[Internet]. 2020 [citado 4 Ago 2020];16(6):311-3 https://doi.org/10.1038/s41581-020-0280-y
Bender-del-Busto J, León-Castellón R, Mendieta-Pedroso M. Enfermedad cerebrovascular y COVID-19. Anales de la Academia de Ciencias de Cuba [Internet]. 2020 [citado 13 Ago 2020];10(2):[aprox. 7 p.]. Disponible en: http://revistaccuba.sld.cu/index.php/revacc/article/view/802
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Bárbara Blas Rodríguez Carrasco, Marcel Deniel Mendieta Pedroso, Efraín Boyeros Fernández
This work is licensed under a Creative Commons Attribution 4.0 International License.
This site is licensed under a